|
1
|
Chen YP, Chan ATC, Le QT, Blanchard P, Sun
Y and Ma J: Nasopharyngeal carcinoma. Lancet. 394:64–80. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cao Y: EBV based cancer prevention and
therapy in nasopharyngeal carcinoma. NPJ Precis Oncol. 1:102017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu M, Li X, Li X and Li G: Signaling
transduction network mediated by tumor suppressor/susceptibility
genes in NPC. Curr Genomics. 10:216–222. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kontny U, Franzen S, Behrends U, Bührlen
M, Christiansen H, Delecluse H, Eble M, Feuchtinger T, Gademann G,
Granzen B, et al: Diagnosis and treatment of nasopharyngeal
carcinoma in children and adolescents - recommendations of the
GPOH-NPC study group. Klin Padiatr. 228:105–112. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Newlaczyl AU and Yu LG: Galectin-3-a
jack-of-all-trades in cancer. Cancer Lett. 313:123–128. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sciacchitano S, Lavra L, Morgante A,
Ulivieri A, Magi F, De Francesco GP, Bellotti C, Salehi LB and
Ricci A: Galectin-3: One molecule for an alphabet of diseases, from
A to Z. Int J Mol Sci. 19:3792018. View Article : Google Scholar
|
|
9
|
Elad-Sfadia G, Haklai R, Balan E and Kloog
Y: Galectin-3 augments K-Ras activation and triggers a Ras signal
that attenuates ERK but not phosphoinositide 3-kinase activity. J
Biol Chem. 279:34922–34930. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Honjo Y, Nangia-Makker P, Inohara H and
Raz A: Down- regulation of galectin-3 suppresses tumorigenicity of
human breast carcinoma cells. Clin Cancer Res. 7:661–668.
2001.PubMed/NCBI
|
|
11
|
Iurisci I, Tinari N, Natoli C, Angelucci
D, Cianchetti E and Iacobelli S: Concentrations of galectin-3 in
the sera of normal controls and cancer patients. Clin Cancer Res.
6:1389–1393. 2000.PubMed/NCBI
|
|
12
|
Nangia-Makker P, Honjo Y, Sarvis R,
Akahani S, Hogan V, Pienta KJ and Raz A: Galectin-3 induces
endothelial cell morphogenesis and angiogenesis. Am J Pathol.
156:899–909. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Méndez-Huergo SP, Blidner AG and
Rabinovich GA: Galectins: Emerging regulatory checkpoints linking
tumor immunity and angiogenesis. Curr Opin Immunol. 45:8–15. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Han YY, Liu K, Xie J, Li F, Wang Y and Yan
B: LINC00114 promoted nasopharyngeal carcinoma progression and
radioresistance in vitro and in vivo through regulating ERK/JNK
signaling pathway via targeting miR-203. Eur Rev Med Pharmacol Sci.
24:2491–2504. 2020.PubMed/NCBI
|
|
15
|
Lv B, Li F, Liu X and Lin L: The
tumor-suppressive role of microRNA-873 in nasopharyngeal carcinoma
correlates with downregulation of ZIC2 and inhibition of AKT
signaling pathway. Cancer Gene Ther. 28:74–88. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hara A and Okayasu I: Cyclooxygenase-2 and
inducible nitric oxide synthase expression in human astrocytic
gliomas: Correlation with angiogenesis and prognostic significance.
Acta Neuropathol. 108:43–48. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Y, Liu F, Han F, Lv L, Tang CE, Xie Z
and Luo F: Omentin-1 is associated with atrial fibrillation in
patients with cardiac valve disease. BMC Cardiovasc Disord.
20:2142020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moloudizargari M, Moradkhani F, Hekmatirad
S, Fallah M, Asghari MH and Reiter RJ: Therapeutic targets of
cancer drugs: Modulation by melatonin. Life Sci. 267:1189342021.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bruce JP, Yip K, Bratman SV, Ito E and Liu
FF: Nasopharyngeal cancer: Molecular landscape. J Clin Oncol.
33:3346–3355. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang LL, Chen WQ, Xue WQ, He YQ, Zheng RS,
Zeng YX and Jia WH: Global trends in incidence and mortality of
nasopharyngeal carcinoma. Cancer Lett. 374:22–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee AW, Ng WT, Chan YH, Sze H, Chan C and
Lam TH: The battle against nasopharyngeal cancer. Radiother Oncol.
104:272–278. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thijssen VL, Heusschen R, Caers J and
Griffioen AW: Galectin expression in cancer diagnosis and
prognosis: A systematic review. Biochim Biophys Acta. 1855:235–247.
2015.PubMed/NCBI
|
|
25
|
Tang CE, Tan T, Li C, Chen ZC, Ruan L,
Wang HH, Su T, Zhang PF and Xiao ZQ: Identification of Galectin-1
as a novel biomarker in nasopharyngeal carcinoma by proteomic
analysis. Oncol Rep. 24:495–500. 2010.PubMed/NCBI
|
|
26
|
Wu KL, Kuo CM, Huang EY, Pan HM, Huang CC,
Chen YF, Hsiao CC and Yang KD: Extracellular galectin-3 facilitates
colon cancer cell migration and is related to the epidermal growth
factor receptor. Am J Transl Res. 10:2402–2412. 2018.PubMed/NCBI
|
|
27
|
Wang L, Li YS, Yu LG, Zhang XK, Zhao L,
Gong FL, Yang XX and Guo XL: Galectin-3 expression and secretion by
tumor-associated macrophages in hypoxia promotes breast cancer
progression. Biochem Pharmacol. 178:1141132020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li CH, Chang YC, Hsiao M and Liang SM:
FOXD1 and Gal-3 form a positive regulatory loop to regulate lung
cancer aggressiveness. Cancers (Basel). 11:18972019. View Article : Google Scholar
|
|
29
|
Teymoortash A, Pientka A, Schrader C,
Tiemann M and Werner JA: Expression of galectin-3 in adenoid cystic
carcinoma of the head and neck and its relationship with distant
metastasis. J Cancer Res Clin Oncol. 132:51–56. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chien MH, Lin CW, Cheng CW, Wen YC and
Yang SF: Matrix metalloproteinase-2 as a target for head and neck
cancer therapy. Expert Opin Ther Targets. 17:203–216. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang X and Zhuang R: Dione-thiophene
conjugate inhibits proliferation and metastasis of nasopharyngeal
carcinoma cells through calcium binding protein-P down-regulation.
Eur J Med Chem. 168:199–206. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lan YY, Chang FH, Tsai JH and Chang Y:
Epstein-Barr virus Rta promotes invasion of bystander tumor cells
through paracrine of matrix metalloproteinase 9. Biochem Biophys
Res Commun. 503:2160–2166. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li YY, Chung GT, Lui VW, To KF, Ma BB,
Chow C, Woo JK, Yip KY, Seo J, Hui EP, et al: Exome and genome
sequencing of nasopharynx cancer identifies NF-kappaB pathway
activating mutations. Nat Commun. 8:141212017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xia Y, Shen S and Verma IM: NF-kappaB, an
active player in human cancers. Cancer Immunol Res. 2:823–830.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang X, Yang J, Bian Z, Shi D and Cao Z:
Long noncoding RNA DANCR promotes nasopharyngeal carcinoma
progression by interacting with STAT3, enhancing IL-6/JAK1/STAT3
signaling. Biomed Pharmacother. 113:1087132019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Farnworth SL, Henderson NC, Mackinnon AC,
Atkinson KM, Wilkinson T, Dhaliwal K, Hayashi K, Simpson AJ, Rossi
AG, Haslett C and Sethi T: Galectin-3 reduces the severity of
pneumococcal pneumonia by augmenting neutrophil function. Am J
Pathol. 172:395–405. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang L, Friess H, Zhu Z, Frigeri L,
Zimmermann A, Korc M, Berberat PO and Büchler MW: Galectin-1 and
galectin-3 in chronic pancreatitis. Lab. Invest. 80:1233–1241.
2000.
|
|
38
|
Li Y, Lv Y, Cheng C, Huang Y, Yang L, He
J, Tao X, Hu Y, Ma Y, Su Y, et al: SPEN induces miR-4652-3p to
target HIPK2 in nasopharyngeal carcinoma. Cell Death Dis.
11:5092020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zheng P, Chen X, Xie J, Chen X, Lin S, Ye
L, Chen L, Lin J, Yu X and Zheng M: Capn4 is induced by and
required for Epstein-Barr virus latent membrane protein 1 promotion
of nasopharyngeal carcinoma metastasis through ERK/AP-1 signaling.
Cancer Sci. 111:72–83. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang Z, Liu G, Mao J, Xie M, Zhao M, Guo
X, Liang S, Li H, Li X and Wang R: IGF-1R inhibition suppresses
cell proliferation and increases radiosensitivity in nasopharyngeal
carcinoma cells. Mediators Inflamm. 2019:54974672019. View Article : Google Scholar : PubMed/NCBI
|
